Crossmark

MED15-TFE3 rearranged renal cell carcinoma: a subtype of TFE3-rearranged renal cell carcinoma with unique clinicopathologic features and better prognosis

Crossref DOI link: https://doi.org/10.1186/s12957-025-04048-x

Published Online: 2025-10-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deng, Zhenggen

Xu, Yanhao

Duan, Enjia

Zhang, Xiaopo

Dong, Xiang

Guo, Hongqian

Gan, Weidong
License Information

Text and Data Mining valid from 2025-10-21

Version of Record valid from 2025-10-21
More Information

Article History

Received: 30 August 2025

Accepted: 23 September 2025

First Online: 21 October 2025

Declarations

:

: The protocol for this research project was approved by the institutional review board of Nanjing Drum Tower Hospital. Owing to the retrospective nature of the study, informed consent was waived.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below